Современная ревматология (Feb 2021)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II

  • N. L. Kozlovskaya,
  • S. K. Solovyev,
  • E. A. Aseeva,
  • T. V. Popkova,
  • T. A. Panafidina,
  • E. L. Nasonov,
  • A. M. Lila,
  • A. A. Mesnyankina,
  • N. Yu. Nikishina

DOI
https://doi.org/10.14412/1996-7012-2021-1-9-14
Journal volume & issue
Vol. 15, no. 1
pp. 9 – 14

Abstract

Read online

The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monitoring, and prognosis for LN, and the management of patients with end-stage renal failure and antiphospholipid syndrome. Attention is paid to the problem of LN and pregnancy, as well as to the management of pediatric patients with kidney damage.

Keywords